You are here

Pembrolizumab

Pfizer Presents Data from Phase 1b Trial Investigating Utomilumab (a 4-1BB agonist) in Combination with a Checkpoint Inhibitor

Yahoo

Sat, 06/4/16 - 06:19 pm

MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at

Yahoo/BusinessWire

Sun, 09/28/14 - 10:10 am

Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen

Yahoo

Tue, 08/26/14 - 08:23 am

non-small cell lung cancer

The real 'exclusive' at Merck: R&D is back in the saddle, baby

Fierce Biotech

Mon, 08/25/14 - 08:48 am

FirstWord Lists: Pharma's biggest pipeline drugs

First Word Pharma

Mon, 08/4/14 - 11:53 am

Bristol-Myers Squibb

First Presentation of Early Data for Pembrolizumab (MK-3475), Merck’s Investigational Anti-PD-1 Antibody, in Advanced Head and Neck Cancer at ASCO 2014

Yahoo/BusinessWire

Sun, 06/1/14 - 12:18 pm

head and neck cancer